1. Pradella P, Azzarini G, Santarossa L, Caberlotto L, Bardin C, Poz A, et al. Cooperation experience in a multicenter study to define the upper limits in a normal population for the diagnostic assessment of the functional Lupus Anticoagulant assays. Clin Chem Lab Med 2013;51:379–85.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000314999000029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3
2. Favaloro EJ, Wong RC. The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours? Autoimmunity Highlights 2010;1:5–14.
3. Favaloro EJ, Wong RC. The antiphospholipid syndrome: diagnosis, pathogenesis, laboratory testing, and management. Semin Thromb Hemost 2012;38:299–304.22618527http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000304352600001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3
4. Les I, Ruiz-Irastorza G, Khamashta MA. Intensity and duration of anticoagulation therapy in antiphospholipid syndrome. Semin Thromb Hemost 2012;38:339–47.22467528http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000304352600006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3
5. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, et al. Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis. update of the guidelines for lupus anticoagulant detection. subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis. J Thromb Haemost 2009;7:1737–40.19624461